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Synthesis and potential antimetastatic activity of monovalent and
divalent -D-galactopyranosyl-(14)-2-
acetamido-2-deoxy-D-glucopyranosides
Qing Li, Bin Su, Hui Li, Xiang-Bao Meng, Meng-Shen Cai, Zhong-Jun Li,
Rou-Li Zhou, Ta-Lin Suo
Introduction
The repeating unit carbohydrate moiety of laminin,
N-acetyllactosamine, might play a role in the preven-
tion of tumor metastasis.1 A precursor of N-acetyllac-
tosamine, 2,3,4,6-tetra-O-acetyl--D-galacto-pyranosyl-
(14)-3,6-di-O-acetyl-2-azido-2-deoxy-D-glucopyran-
osyl nitrate was first prepared and purified,2–6 and then
used as the starting material in a synthesis of N-acetyl-
lactosamine and its derivatives.
Results and discussion
2,3,4,6-Tetra-O -acetyl - -D -galactopyranosyl - (14)-
3,6-di-O-acetyl-2-azido-2-deoxy-D-glucopyranosyl ni-
trate (1)6 was treated with NaNO2 and H2O in 1,4-diox-
ane for 10 h at 80 °C to give hemiacetal 2,7 which then
reacted with CCl3CN and 1,8-diazabicyclo[5,4,0]undec-
7-ene (DBU) in dry CH2Cl2 for 3 h at 0 °C to give the
imidate 3. Imidate 3 reacted with the spacer-arm agly-
cons in CH2Cl2 at room temperature with Me3SiOTf as
promoter to afford the -glycosides (5 or 6) in yields of
65–70%. Treating 1 with LiBr2 afforded bromide 4,
which then reacted in the presence of tetrabutyl ammo-
nium bromide (Bu4NBr)8–10 with the spacer-arm agly-
cons to give the -glycosides (7 or 8) in yields of
38–42% (Scheme 1).
When imidate 3 reacted with 5 or 6 in the presence of
Me3SiOTf, the asymmetric divalent glycosides (9 and
10) were mainly obtained. On the other hand,
BF3·OEt2, a weaker promoter than Me3SiOTf, when
used in the reaction of 3 and 5 or 6 gave the symmetric
divalent glycosides (11 and 12) of -configuration selec-
tively. The -symmetric divalent glycosides (13 and 14)
were obtained selectively when 7 or 8 reacted with 3 in
the presence of Me3SiOTf, but asymmetric divalent
glycosides 9 or 10 were obtained when BF3·OEt2 was
used in these reactions (Scheme 2).
Treating the azides 5–14 with thioacetic acid11,12 for
30 h at room temperature gave the corresponding ac-
etamides 15–24 in yields of 48–80%, and these were
deprotected to give the target compounds 25–34 in
yields of 93–98% (Scheme 3).
The potential antimetastatic activity of compounds
25–34 was determined by measurements of inhibitory
effects on cancer-cell attachment, spreading, and migra-
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Table 1
Cancer-cell attachment and spreading on LN-1 substrate
Cancer-cell attachmentEntry
rate (%) a
100Laminin+BSA(control)
Laminin+BSA+LacNAc 82.6
Laminin+BSA+compound 25 70.3
57.6 bLaminin+BSA+compound 26
Laminin+BSA+compound 27 96.8
89.4Laminin+BSA+compound 28
76.5Laminin+BSA+compound 29
81.0Laminin+BSA+compound 30
101Laminin+BSA+compound 31
99.0Laminin+BSA+compound 32
53.5 bLaminin+BSA+compound 33
Laminin+BSA+compound 34 55.7 b
a At concentration 2 (7 mM for monovalent glycosides and
3.5 mM for divalent glucosides).
b These compounds showed a significant inhibitory effect.
orated under diminished pressure. The resulting oily
brown residue was purified by flash chromatography
with 2:5 petroleum ether (60–90 °C)–EtOAc as eluent
to afford 0.32 g of 5 as a colorless syrup, yield 70%;
[ ]D25 +32.0° (c 0.5, CHCl3); 1H NMR (CDCl3):  5.35
(dd, 1 H, H-4), 5.09 (dd, 1 H, H-2), 4.99 (dd, 1 H,
H-3), 4.94 (dd, 1 H, H-3), 4.46 (d, 1 H, J1, 2 8.08 Hz,
H-1), 4.44 (d, 1 H, J1, 2 7.84 Hz, H-1), 4.51, 4.18–4.06
(m, 4 H, H-6a, 6b, H-6a, 6b), 4.03–3.80 (m, 3 H, H-4,
5, H-5), 3.74–3.58 (m, 8 H, CH2O), 3.10 (dd, 1 H,
H-2), 2.17–1.96 (6s, 18 H, 6×CH3CO); 13C NMR
(CDCl3):  170.3–168.9 (6 C, CH3CO), 102.1 (C-1),
100.9 (C-1), 75.9 (C-4), 72.8 (CH2O), 72.4 (CH2O),
71.8 (C-3), 71.0 (C-3), 70.7 (C-5), 70.1 (CH2O), 69.5
(C-5), 69.1 (C-2), 66.6 (C-4), 63.9 (C-2), 61.8 (C-6),
61.7 (CH2O), 60.8 (C-6), 20.8–20.5 (6 C, CH3CO).
Anal. Calcd for C28H41N3O18: C, 47.53; H, 5.84; N,
5.94. Found: C, 47.17; H, 5.59; N, 5.49.
8-Hydroxy-3,6-dioxaoctyl 2,3,4,6-tetra-O-acetyl--
D-galactopyranosyl-(14)-3,6-di-O-acetyl-2-azido-2-
deoxy--D-glucopyranoside (6)
Compound 6 was prepared as described for the prepa-
ration of 5 and the crude product was purified by
chromatography with 2:7 petroleum ether (60–90 °C)–
EtOAc as eluent. A colorless syrup was obtained in
65% yield; [ ]D25 +23.7° (c 1.35, CHCl3). 1H NMR
(CDCl3):  5.33 (dd, 1 H, H-4), 5.09 (dd, 1 H, H-2),
5.00 (dd, 1 H, H-3), 4.94 (dd, 1 H, H-3), 4.50 (d, 1 H,
J1, 2 8.06 Hz, H-1), 4.44 (d, 1 H, J1, 2 7.84 Hz, H-1),
4.47, 4.15–3.82 (m, 6 H, H-5, H-5, H-6a, 6b, H-6a,
6b), 3.41 (dd, 1 H, H-2), 3.73–3.59 (m, 13 H, H-4,
CH2O), 2.15–1.95 (6s, 18 H, 6×CH3CO); 13C NMR
(CDCl3):  170.3–169.0 (6 C, CH3CO), 101.9 (C-1),
100.9 (C-1), 76.0 (C-4), 72.6 (CH2O), 72.4 (CH2O),
71.9 (C-3), 71.0 (C-3), 70.7 (C-5), 70.5 (CH2O), 70.3
(CH2O), 69.1 (C-5), 69.0 (C-2), 67.7 (CH2O), 66.7
(C-4), 63.9 (C-2), 61.9 (C-6), 61.6 (CH2O), 60.8 (C-6),
20.9–20.5 (6 C, CH3CO). Anal. Calcd for
C30H45N3O19: C, 47.94; H, 6.03; N, 5.59. Found: C,
47.57; H, 5.88; N, 5.31.
5-Hydroxy-3-oxapentyl 2,3,4,6-tetra-O-acetyl--D-
galactopyranosyl-(14)-3,6-di-O-acetyl-2-azido-2-
deoxy--D-glucopyranoside (7)
Compound 1 (1 g) was dissolved in anhydrous CH3CN
(10 mL), and then LiBr (1 g) and 4 A molecular sieves
(2 g) were added. The mixture was stirred for 6 h at
room temperature, the sieves were filtered off and the
filtrate concentrated to give 4 (0.8 g) as a yellow syrup.2
To a solution of 4 and diethylene glycol (1 mL) in dry
CH2Cl2 (15 mL), were added Bu4NBr (0.5 g) and 4 A
molecular sieves (1 g), and the mixture was stirred at
room temperature for 24 h, the mixture was then
Table 2
Migration of BEL-7402 human hepatocellular carcinoma cells
and invasion analysis a
Number ofNumber of
invading cellsmigrating cells
26.674.19In the absence of 352.33
compound 26
13.61.46 bIn the presence of 9.81.86 b
compound 26
a Experimental method see Ref. 14.
b P0.01 versus control group.
was added. The organic layer was washed with water,
dried, and concentrated. The crude product was
purified by chromatography (1:1 petroleum ether (60–
90 °C)–EtOAc) to give 2 (2.4 g) as colorless syrup in
85% yield. Compound 2 (1 g) was dissolved in anhy-
drous CH2Cl2 (12 mL), and then CCl3CN (1 mL) and
DBU (0.2 mL) were added. The solution was stirred for
3 h at 0 °C, concentrated, and the crude product
purified by chromatography [1:1 petroleum ether (60–
90 °C)–EtOAc] to afford 3 (1 g) as a yellow syrup in
yield of 81%.
5-Hydroxy-3-oxapentyl 2,3,4,6-tetra-O-acetyl--D-
galactopyranosyl-(14)-3,6-di-O-acetyl-2-azido-2-
deoxy--D-glucopyranoside (5)
To a solution of 3 (0.5 g, 0.65 mmol) and diethylene
glycol (0.5 mL) in dry CH2Cl2 (10 mL), Me3SiOTf was
added and the mixture was stirred at room temperature
for 16 h. The mixture was then diluted with CH2Cl2 (20
mL) and washed with water, dried (Na2SO4) and evap-
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diluted with CH2Cl2 (30 mL) and washed with water,
dried (Na2SO4), and evaporated under diminished pres-
sure. The resulting oily brown residue was purified by
flash chromatography with 2:5 petroleum ether (60–
90 °C)–EtOAc as eluent and 0.32 g of 7 was obtained
as a colorless syrup. The total yield of two steps was
38%; [ ]D25 +61.9° (c 1.55, CHCl3); 1H NMR (CDCl3):
 5.46 (dd, 1 H, H-3), 5.36 (dd, 1 H, H-4), 5.12 (dd, 1
H, H-2), 5.02 (d, 1 H, J1, 2 3.40 Hz, H-1), 4.97 (dd, 1 H,
H-3), 4.48 (d, 1 H, J1, 2 7.96 Hz, H-1), 4.44, 4.19–4.09
(m, 4 H, H-6a, 6b, H-6a, 6b), 4.06–3.83 (m, 3 H, H-4,
5, H-5), 3.74–3.59 (m, 8 H, CH2O), 3.13 (dd, 1 H,
H-2), 2.18–1.96 (6s, 18 H, 6×CH3CO); 13C NMR
(CDCl3):  170.4–169.2 (6 C, CH3CO), 101.2 (C-1),
98.0 (C-1), 76.5 (C-4), 72.6 (CH2O), 71.0 (C-3), 70.6
(C-5), 70.1 (CH2O), 70.0 (C-3), 69.1 (C-2), 68.5 (C-5),
67.7 (CH2O), 66.6 (C-4), 62.0 (C-6), 61.8 (CH2O), 61.1
(C-6), 60.8 (C-2), 20.9–20.5 (6 C, CH3CO). Anal.
Calcd for C28H41N3O18: C, 47.53; H, 5.84; N, 5.94.
Found: C, 47.70; H, 6.05; N, 5.51.
8-Hydroxy-3,6-dioxaoctyl 2,3,4,6-tetra-O-acetyl--
D-galactopyranosyl-(14)-3,6-di-O-acetyl-2-azido-2-
deoxy--D-glucopyranoside (8)
Compound 8 was prepared as described for the prepa-
ration of 7 and the crude product was purified by
chromatography with 2:7 petroleum ether (60–90 °C)–
EtOAc as eluent to afford a colorless syrup in 42%
yield; [ ]D25 +80.0° (c 1.40, CHCl3); 1H NMR (CDCl3):
 5.49 (dd, 1 H, H-3), 5.36 (dd, 1 H, H-4), 5.12 (dd, 1
H, H-2), 5.04 (d, 1 H, J1, 2 3.52 Hz, H-1), 4.96 (dd, 1 H,
H-3), 4.49 (d, 1 H, J1, 2 7.88 Hz, H-1), 4.47, 4.17–3.88
(m, 6 H, H-5, H-5, H-6a, 6b, H-6a, 6b), 3.75–3.60 (m,
13 H, H-4, CH2O), 3.10 (dd, 1 H, H-2), 2.17–1.97 (6s,
18 H, 6×CH3CO); 13C NMR (CDCl3):  170.4–169.2
(6 C, CH3CO), 101.2 (C-1), 98.1 (C-1), 76.5 (C-4), 72.5
(CH2O), 71.1 (C-3), 70.8 (C-5), 70.6 (CH2O), 70.1
(C-3), 70.4 (CH2O), 69.9 (CH2O), 69.2 (C-2), 68.4
(C-5), 67.7 (CH2O), 66.6 (C-4), 62.0 (C-6), 61.8
(CH2O), 61.0 (C-6), 60.8 (C-2), 21.0–20.52 (6 C,
CH3CO). Anal. Calcd for C30H45N3O19: C, 47.94; H,
6.03; N, 5.59. Found: C, 47.76; H, 6.18; N, 5.80.
1-[2,3,4,6-Tetra-O-acetyl--D-galactopyranosyl-
(14)-3,6-di-O-acetyl-2-azido-2-deoxy--D-glucopyran-
osyloxy-5-[2,3,4,6-tetra-O-acetyl--D-galactopyranosyl-
(14)-3,6-di-O-acetyl-2-azido-2-deoxy--D-glucopyran-
osyloxy-3-oxapentane (9)
A mixture of 3 (0.5 g, 0.65 mmol) and 5 (0.3 g, 0.42
mmol) in dry CH2Cl2 (15 mL) in the presence of
powered molecular sieves 4 A (1 g) was cooled to
−20 °C and Me3SiOTf (0.1 mL) was added dropwise
with stirring. The mixture was kept for 1 h at −20 to
0 °C and 24 h at room temperature, then the mixture
was filtered and filtrate was washed with aqueous
NaHCO3 and water, dried (Na2SO4) and concentrated.
The residue was subjected to chromatography on silica
gel [4:5 petroleum ether (60–90 °C)–EtOAc] to give 9
(0.24 g) as a colorless syrup in 43% yield; [ ]D25 +57.1°
(c 0.63, CHCl3); 1H NMR (CDCl3):  5.47 (dd, 1 H,
H-3), 5.35 (dd, 2 H, H-4, H-4), 5.11–5.07 (m, 2 H,
H-2, H-2), 5.05 (d, 1 H, J1, 2 3.54 Hz, H-1), 4.98–
4.95 (m, 3 H, H-3, H-3, H-3), 4.49 (d, 1 H, J1, 2 7.99
Hz, 1 H, H-1), 4.47 (d, 2H, J1, 2 7.90 Hz, H-1, H-1),
4.45, 4.18–4.08 (m, 8 H, H-6a, 6b, H-6a, 6b, H-6a,
6b, H-6a, 6b), 3.98–3.76 (m, 6 H, H-4, 5, H-5,
H-4, 5, H-5), 3.75–3.65 (m, 8 H, CH2O), 3.45 (dd, 1
H, H-2), 3.12 (dd, 1 H, H-2), 2.17–1.96 (12s, 36 H,
12×CH3CO); 13C NMR (CDCl3):  170.2–168.9 (12
C, CH3CO), 101.9 (C-1), 101.1 (C-1), 100.9 (C-1),
97.8 (C-1), 76.5 (C-4), 75.9 (C-4), 72.6 (CH2O), 71.9
(C-3), 71.0, 70.9 (2 C, C-3, C-3), 70.7, 70.6 (2 C,
C-5, C-5), 70.5 (CH2O), 70.2 (C-3), 70.1 (CH2O),
69.3, 69.1 (2 C, C-2, C-2), 69.1, 68.4 (2 C, C-5,
C-5), 67.4 (CH2O), 66.6, 66.5 (2C, C-4, C-4), 63.9
(C-2), 61.9, 61.8 (2 C, C-6, C-6), 61.0, 60.8 (2 C,
C-6, C-6), 60.7 (C-2), 20.9–20.4 (12 C, CH3CO).
Anal. Calcd for C52H72N6O33: C, 47.49; H, 5.56; N,
6.12. Found: C, 47.19; H, 5.49; N, 5.81.
1-[2,3,4,6-Tetra-O-acetyl--D-galactopyranosyl-
(14)-3,6-di-O-acetyl-2-azido-2-deoxy--D-glucopyran-
osyloxy-8-[2,3,4,6-tetra-O-acetyl--D-galactopyranosyl-
(14)-3,6-di-O-acetyl-2-azido-2-deoxy--D-glucopyran-
osyloxy-3-dioxaoctane (10)
Compound 10 was prepared as described for the prepa-
ration of 9. The crude product was purified by chro-
matography with 2:3 petroleum ether (60–90 °C)–
EtOAc to afford a colorless syrup in 40% yield; [ ]D25
+66.1° (c 2.48, CHCl3); 1H NMR (CDCl3):  5.47 (dd,
1 H, H-3), 5.35 (dd, 2 H, H-4, H-4), 5.10–5.09 (m,
2 H, H-2, H-2), 5.04 (d, 1 H, J1, 2 3.35 Hz, H-1),
4.96–4.94 (m, 3 H, H-3, H-3, H-3), 4.49 (d, 1 H, J1,
2 7.96 Hz, 1 H, H-1), 4.47 (d, 2 H, J1, 2 7.90 Hz, H-1,
H-1), 4.45, 4.17–4.07 (m, 8 H, H-6a, 6b, H-6a, 6b,
H-6a, 6b, H-6a, 6b), 3.98–3.72 (m, 6 H, H-4, 5,
H-5, H-4, 5, H-5), 3.72–3.67 (m, 12 H, CH2O), 3.42
(dd, 1 H, H-2), 3.11 (dd, 1 H, H-2), 2.18–1.97 (12s, 36
H, 12×CH3CO); 13C NMR (CDCl3):  170.3–168.9
(12 C, CH3CO), 102.0 (C-1), 101.1 (C-1), 100.9 (C-
1), 98.1 (C-1), 76.5 (C-4), 76.0 (C-4), 72.7 (CH2O),
72.6 (CH2O), 71.9 (C-3), 71.0, 70.9 (2 C, C-3, C-3),
70.7, 70.3 (2 C, C-5, C-5), 70.2 (CH2O), 70.1 (C-3),
70.0 (CH2O), 69.4 (CH2O), 69.3, 69.1 (2 C, C-2,
C-2), 69.0, 68.4 (2 C, C-5, C-5), 67.7 (CH2O), 66.6,
66.5 (2 C, C-4, C-4), 63.9 (C-2), 61.9, 61.0 (2 C,
C-6, C-6), 60.8, 60.7 (2 C, C-6, C-6), 60.6 (C-2),
20.9–20.4 (12 C, CH3CO). Anal. Calcd for
C54H76N6O34: C, 47.93; H, 5.66; N, 6.21. Found: C,
47.73; H, 5.84; N, 5.92.
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3-Oxapent-1,5-diyl bis[2,3,4,6-tetra-O-acetyl--D-
galactopyranosyl-(14)-3,6-di-O-acetyl-2-azido-2-
deoxy--D-glucopyranoside] (11)
A mixture of 3 (0.5 g, 0.65 mmol) and 5 (0.3 g, 0.42
mmol) in dry CH2Cl2 (15 mL) in the presence of
powered molecular sieves 4 A (1 g) was cooled to 0 °C
and BF3·OEt2 (0.2 mL) was added dropwise with stir-
ring. The mixture was kept for 1 h at −20 to 0 °C and
24 h at room temperature, then the mixture was filtered
and filtrate was washed with aqueous sodium bicarbon-
ate and water, dried (Na2SO4) and concentrated. The
residue was subjected to chromatography on silica gel
[4:5 petroleum ether (60–90 °C)–EtOAc] to give 11
(0.15 g) as a colorless syrup (27%); [ ]D25 +17.9° (c 2.68,
CHCl3); 1H NMR (CDCl3):  5.36 (dd, 1 H, H-4), 5.12
(dd, 1 H, H-2), 4.98 (dd, 1 H, H-3), 4.95 (dd, 1 H,
H-3), 4.50 (d, 1 H, J1, 2 8.00 Hz, H-1), 4.47 (d, 1 H, J1,
2 8.00 Hz, 1 H, H-1), 4.45, 4.20–4.05 (m, 4 H, H-6a,
6b, H-6a, 6b), 4.01–3.81 (m, 3 H, H-4, 5, H-5),
3.74–3.69 (m, 4 H, CH2O), 3.43 (dd, 1 H, H-2), 2.17–
1.98 (6s, 18 H, 6×CH3CO); 13C NMR (CDCl3):
 170.3–168.9 (6 C, CH3CO), 102.1 (C-1), 100.9
(C-1), 76.0 (C-4), 72.9 (CH2O), 72.0 (C-3), 70.8
(C-3), 70.5 (C-5), 70.2 (CH2O), 69.4 (C-5), 69.2
(C-2), 66.8 (C-4), 64.0 (C-2), 62.0 (C-6), 60.9 (C-6),
20.9–20.4 (6 C, CH3CO). Anal. Calcd for
C52H72N6O33: C, 47.49; H, 5.56; N, 6.12. Found: C,
47.70; H, 5.65; N, 6.36.
3,6-Dioxaoct-1,8-diyl bis[2,3,4,6-tetra-O-acetyl--
D-galactopyranosyl-(14)-3,6-di-O-acetyl-2-azido-2-
deoxy--D-glucopyranoside] (12)
Compound 12 was prepared as described for the prepa-
ration of 11. The crude product was purified by chro-
matography with 2:3 petroleum ether (60–90 °C)–
EtOAc to afford a colorless syrup in 30% yield of; [ ]D25
+8.9° (c 2.25, CHCl3); 1H NMR (CDCl3):  5.36 (dd,
1 H, H-4), 5.09 (dd, 1 H, H-2), 4.97 (dd, 1 H, H-3),
4.94 (dd, 1 H, H-3), 4.48 (d, 1 H, J1, 2 8.06 Hz, H-1),
4.44 (d, 1 H, J1, 2 8.00 Hz, H-1), 4.42, 4.20–4.06 (m, 4
H, H-6a, 6b, H-6a, 6b), 4.02–3.81 (m, 3 H, H-4, 5,
H-5), 3.75–3.65 (m, 6 H, CH2O), 3.42 (dd, 1 H, H-2),
2.18–1.98 (6s, 18 H, 6×CH3CO); 13C NMR (CDCl3):
 170.3–169.0 (6 C, CH3CO), 102.1 (C-1), 101.0 (C-1),
76.0 (C-4), 72.6 (CH2O), 71.8 (C-3), 71.0 (C-3), 70.7
(C-5), 70.3 (CH2O), 70.0 (CH2O), 69.4 (C-5), 69.0
(C-2), 66.6 (C-4), 63.9 (C-2), 61.9 (C-6), 60.8 (C-6),
20.9–20.5 (6 C, CH3CO). Anal. Calcd for
C54H76N6O34: C, 47.93; H, 5.66; N, 6.21. Found: C,
48.00; H, 5.74; N, 6.18.
3-Oxapent-1,5-diyl bis[2,3,4,6-tetra-O-acetyl--D-
galactopyranosyl-(14)-3,6-di-O-acetyl-2-azido-2-
deoxy--D-glucopyranoside] (13)
A mixture of 3 (0.5 g, 0.65 mmol) and 7 (0.3 g, 0.42
mmol) in dry CH2Cl2 (15 mL) in the presence of
powered molecular sieves 4 A (1 g) was cooled to
−20 °C and Me3SiOTf (0.1 mL) was added dropwise
with stirring. The mixture was kept for 1 h at −20 to
0 °C and 24 h at room temperature, then the mixture
was filtered and the filtrate was washed with aqueous
NaHCO3 and water, dried (Na2SO4) and concentrated.
The residue was subjected to chromatography on silica
gel [4:5 petroleum ether (60–90 °C)–EtOAc] to give 13
(0.23 g) as a colorless syrup (41%); [ ]D25 +52.2° (c 1.15,
CHCl3); 1H NMR (CDCl3):  5.47 (dd, 1 H, H-3), 5.36
(dd, 1 H, H-4), 5.11 (dd, 1 H, H-2), 5.04 (d, 1 H, J1, 2
3.50 Hz, H-1), 4.96 (dd, 1 H, H-3), 4.48 (d, 1 H, J1, 2
7.50 Hz, 1 H, H-1), 4.44, 4.21–4.04 (m, 4 H, H-6a, 6b,
H-6a, 6b), 3.99–3.82 (m, 3 H, H-4, 5, H-5), 3.76–3.69
(m, 4 H, CH2O), 3.10 (dd, 1 H, H-2), 2.17–1.97 (6s, 18
H, 6×CH3CO); 13C NMR (CDCl3):  170.2–169.0 (6
C, CH3CO), 101.1 (C-1), 98.1 (C-1), 76.6 (C-4), 71.1
(C-3), 70.7 (C-5), 70.4 (CH2O), 70.2 (C-3), 69.2 (C-2),
68.6 (C-5), 67.6 (CH2O), 66.7 (C-4), 62.0 (C-6), 61.1
(C-6), 60.8 (C-2), 20.8–20.5 (6 C, CH3CO). Anal.
Calcd for C52H72N6O33: C, 47.49; H, 5.56; N, 6.12.
Found: C, 47.23; H, 5.83; N, 6.34.
3,6-Dioxaoct-1,8-diyl bis[2,3,4,6-tetra-O-acetyl--
D-galactopyranosyl-(14)-3,6-di-O- acetyl-2-azido-2-
deoxy--D-glucopyranoside] (14)
Compound 14 was prepared as described for the prepa-
ration of 13. The crude product was purified by chro-
matography with 2:3 petroleum ether (60–90 °C)–
EtOAc to afford a colorless syrup in 39% yield; [ ]D25
+65.4° (c 1.04, CHCl3); 1H NMR (CDCl3):  5.46 (dd,
1 H, H-3), 5.36 (dd, 1 H, H-4), 5.11 (dd, 1 H, H-2),
5.03 (d, 1 H, J1, 2 3.30 Hz, H-1), 4.95 (dd, 1 H, H-3),
4.48 (d, 1 H, J1, 2 7.50 Hz, H-1), 4.43, 4.20–4.07 (m, 4
H, H-6a, 6b, H-6a, 6b), 4.03–3.83 (m, 3 H, H-4, 5,
H-5), 3.76–3.65 (m, 6 H, CH2O), 3.13 (dd, 1 H, H-2),
2.16–1.97 (6s, 18 H, 6×CH3CO); 13C NMR (CDCl3):
 170.3–169.0 (6 C, CH3CO), 101.1 (C-1), 98.1 (C-1),
76.6 (C-4), 71.1 (C-3), 70.7 (C-5), 70.2 (C-3), 70.1
(CH2O), 69.5 (CH2O), 69.3 (C-2), 68.5 (C-5), 67.8
(CH2O), 66.8 (C-4), 62.0 (C-6), 60.9 (C-6), 60.8 (C-2),
20.9–20.4 (6 C, CH3CO). Anal. Calcd for
C54H76N6O34: C, 47.93; H, 5.66; N, 6.21. Found: C,
47.79; H, 5.56; N, 5.92.
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5-Hydroxy-3-oxapentyl 2,3,4,6-tetra-O-acetyl--D-
galactopyranosyl-(14)-3,6-di-O-acetyl-2-acetamido-2-
deoxy--D-glucopyranoside (15)
A solution of 5 (0.2 g) in thioacetic acid (3 mL) was
stirred at room temperature for 36 h, then concen-
trated. The residue was eluted from a column of silica
gel with 50:1 CHCl3–MeOH to give 15 as a colorless
syrup (0.16 g, 80%); [ ]D25 −12.8° (c 0.94, CHCl3); 1H
NMR1 H NMR (CDCl3):  6.72 (d, 1 H, NH), 5.36
(dd, 1 H, H-4), 5.11 (dd, 1 H, H-2), 5.05 (dd, 1 H,
H-3), 4.97 (dd, 1 H, H-3), 4.73 (d, 1 H, J1, 2 7.86 Hz,
H-1), 4.50 (d, 1 H, J1, 2 7.89 Hz, H-1), 4.46, 4.15–4.11
(m, 4 H, H-6a, 6b, H-6a, 6b), 4.08 (dd, 1 H, H-2), 3.90
(m, 1 H, H-5), 3.88 (m, 1 H, H-5), 3.80 (m, 1 H, H-4),
3.77–3.60 (m, 8 H, CH2O), 2.15–1.97 (7s, 21 H, 6×
CH3CO, CH3CONH); 13C NMR (CDCl3):  170.6–
169.3 (7 C, 6×COCH3, CONH), 101.5 (C-1), 101.0
(C-1), 75.8 (C-4), 72.8 (CH2O), 72.7 (C-3), 72.2
(CH2O), 71.1 (CH2O), 70.8 (C-3), 70.7 (C-5), 69.1
(C-2), 68.5 (C-5), 66.6 (C-4), 62.5 (C-6), 61.7 (CH2O),
60.7 (C-6), 53.1 (C-2), 23.0 (CH3CONH), 20.8–20.4 (6
C, CH3CO). Anal. Calcd for C30H45NO19: C, 49.79; H,
6.27; N, 1.94. Found: C, 49.43; H, 6.19; N, 1.76.
8-Hydroxy-3,6-dioxaoctyl 2,3,4,6-tetra-O-acetyl-
-D-galactopyranosyl-(14)-3,6-di-O-acetyl-2-acetam-
ido-2-deoxy--D-glucopyranoside (16)
Compound 16 was prepared as described for the prepa-
ration of 15. The crude product was purified by chro-
matography with 40:1 CHCl3–MeOH to afford a
colorless syrup in 72% yield; [ ]D25 −11.1° (c 0.72,
CHCl3); 1H NMR (CDCl3):  6.86 (d, 1 H, NH), 5.34
(d, 1 H, H-4), 5.10 (dd, 1 H, H-2), 5.03 (d, 1 H, H-3),
4.96 (dd, 1 H, H-3), 4.69 (d, 1 H, J1, 2 8.10 Hz, H-1),
4.49 (d, 1 H, J1, 2 7.80 Hz, H-1), 4.46, 4.11–4.09 (m, 4
H, H-6a, 6b, H-6a, 6b), 4.07 (dd, 1 H, H-2), 3.89 (m,
1 H, H-5), 3.87 (m, 1 H, H-5), 3.82 (m, 1 H, H-4),
3.76–3.61 (m, 12 H, CH2O), 2.14–1.97 (7s, 21 H,
6×CH3CO, CH3CONH); 13C NMR (CDCl3):  171.2
(NHCO), 170.6–169.2 (6 C, COCH3), 101.8 (C-1),
100.9 (C-1), 76.2 (C-4), 73.8 (CH2O), 72.4 (C-3), 71.5
(CH2O), 70.9 (C-3), 70.7 (C-5), 70.5 (CH2O), 70.1
(CH2O), 69.2 (C-2), 68.4 (C-5), 67.1 (CH2O), 66.7
(C-4), 62.4 (C-6), 61.2 (CH2O), 60.8 (C-6), 53.6 (C-2),
23.0 (CH3CONH), 20.8–20.3 (6 C, CH3CO). Anal.
Calcd for C32H49NO20: C, 50.06; H, 6.43; N, 1.82.
Found: C, 49.89; H, 6.51; N, 1.69.
5-Hydroxy-3-oxapentyl 2,3,4,6-tetra-O-acetyl--D-
galactopyranosyl-(14)-3,6-di-O-acetyl-2-acetamido-2-
deoxy--D-glucopyranoside (17)
Compound 17 was prepared as described for the prepa-
ration of 15. The crude product was purified by chro-
matography with 40:1 CHCl3–MeOH to afford a
colorless syrup in 75% yield; [ ]D25 +62.3° (c 1.22,
CHCl3); 1H NMR (CDCl3):  6.39 (d, 1 H, NH), 5.35
(dd, 1 H, H-4), 5.25 (dd, 1 H, H-3), 5.13 (dd, 1 H,
H-2), 4.97 (dd, 1 H, H-3), 4.83 (d, 1 H, J1, 2 3.44 Hz,
H-1), 4.52 (d, 1 H, J1, 2 7.89 Hz, H-1), 4.24 (dd, 1 H,
H-2), 4.47, 4.12–4.06 (m, 4 H, H-6a, 6b, H-6a, 6b),
3.94 (m, 1 H, H-5), 3.90 (m, 1 H, H-5), 3.79 (m, 1 H,
H-4), 3.77–3.62 (m, 8 H, CH2O), 2.15–1.95 (7s, 21 H,
6×CH3CO, CH3CONH); 13C NMR (CDCl3):  171.1
(CONH), 170.5–169.3 (6 C, COCH3), 101.2 (C-1), 97.3
(C-1), 76.3 (C-4), 72.6 (CH2O), 71.5 (C-3), 70.9 (C-3),
70.6 (C-5), 69.7 (CH2O), 69.2 (C-2), 68.6 (C-5), 67.4
(CH2O), 66.6 (C-4), 62.0 (C-6), 61.5 (CH2O), 60.7
(C-6), 52.0 (C-2), 23.0 (CH3CONH), 20.9–20.4 (6 C,
CH3CO). Anal. Calcd for C30H45NO19: C, 49.79; H,
6.27; N, 1.94. Found: C, 49.36; H, 6.01; N, 1.89.
8-Hydroxy-3,6-dioxaoctyl 2,3,4,6-tetra-O-acetyl-
-D-galactopyranosyl-(14)-3,6-di-O-acetyl-2-acetam-
ido-2-deoxy--D-glucopyranoside (18)
Compound 18 was prepared as described for the prepa-
ration of 15. The crude product was purified by chro-
matography with 40:1 CHCl3–MeOH to afford a
colorless syrup in 70% yield; [ ]D25 +50.8° (c 0.63,
CHCl3); 1H NMR (CDCl3):  7.32 (d, 1 H, NH), 5.34
(d, 1 H, H-4), 5.27 (d, 1 H, H-3), 5.13 (dd, 1 H, H-2),
4.96 (dd, 1 H, H-3), 4.76 (d, 1 H, J1, 2 3.30 Hz, H-1),
4.54 (d, 1 H, J1, 2 7.80 Hz, H-1), 4.47, 4.12–4.07 (m, 4
H, H-6a, 6b, H-6a, 6b), 4.29 (dd, 1 H, H-2), 3.90 (m,
1 H, H-5), 3.88 (m, 1 H, H-5), 3.81 (m, 1 H, H-4),
3.77–3.62 (m, 12 H, CH2O), 2.15–1.95 (7s, 21 H,
6×CH3CO, CH3CONH); 13C NMR (CDCl3): 
170.6–169.2 (7C, 6×COCH3, NHCO), 101.1 (C-1),
97.4 (C-1), 76.6 (C-4), 72.7 (CH2O), 71.6 (C-3), 71.0
(C-3), 70.9 (CH2O), 70.6 (C-5), 70.3 (CH2O), 69.9
(CH2O), 69.3 (C-2), 68.5 (C-5), 66.8 (CH2O), 66.6
(C-4), 62.0 (C-6), 61.8 (CH2O), 60.7 (C-6), 51.7 (C-2),
22.8 (CH3CONH), 20.8–20.4 (6 C, CH3CO). Anal.
Calcd for C32H49NO20: C, 50.06; H, 6.43; N, 1.82.
Found: C, 50.03; H, 6.11; N, 1.71.
1-[2,3,4,6-Tetra-O-acetyl--D-galactopyranosyl-
(14)-3,6-di-O-acetyl-2-acetamido-2-deoxy--D-
glucopyranosyloxy-5-[2,3,4,6-tetra-O-acetyl--D-
galactopyranosyl-(14)-3,6-di-O-acetyl-2-acetamido-2-
deoxy--D-glucopyranosyloxy-3-oxapentane (19)
A solution of 9 (0.25 g) in thioacetic acid (3 mL) was
stirred for 50 h at room temperature, then concen-
trated. The residue was eluted from a column of silica
gel with 40:1 CHCl3–MeOH to give 19 as a colorless
syrup (0.15 g, 59%); [ ]D25 +38.5° (c 0.52, CHCl3); 1H
NMR (CDCl3):  6.48, 6.35 (d, 2 H, NH, NH), 5.36
(dd, 2 H, H-4, H-4), 5.22 (dd, 1 H, H-3), 5.12–5.10
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(m, 2 H, H-2, H-2), 5.07 (1 H, H-3), 4.96–4.94 (m,
2H, H-3, H-3), 4.83 (d, 1 H, J1, 2 4.00 Hz, H-1), 4.71
(d, 1 H, J1, 2 8.50 Hz, 1 H, H-1), 4.58 (d, 1 H, J1, 2
8.00 Hz, 1 H, H-1), 4.52 (d, 1 H, J1, 2 8.00 Hz, 1 H,
H-1), 4.50, 4.11–4.08 (m, 8 H, H-6a, 6b, H-6a, 6b,
H-6a, 6b, H-6a, 6b), 4.27 (dd, 1 H, H-2), 4.07 (dd,
1 H, H-2), 3.91–3.79 (m, 6 H, H-4, 5, H-5, H-4, 5,
H-5), 3.76–3.56 (m, 8 H, CH2O), 2.19–1.96 (14s, 42
H, CH3CONH, CH3CONH, 12×CH3CO); 13C
NMR (CDCl3):  171.0, 170.8 (2 C, CH3CONH,
CH3CONH), 170.5–169.2 (12 C, CH3CO), 101.2 (C-
1), 101.0 (C-1), 100.0 (C-1), 97.3 (C-1), 76.3 (C-4),
76.0 (C-4), 72.7 (C-3), 72.5 (CH2O), 71.8 (C-3), 71.2,
70.9 (2 C, C-3, C-3), 70.8, 70.6 (2 C, C-5, C-5),
70.5 (CH2O), 69.3 (CH2O), 69.2, 69.0 (2 C, C-2,
C-2), 69.1, 68.2 (2 C, C-5, C-5), 67.6 (CH2O), 66.5,
66.2 (2 C, C-4, C-4), 62.1, 61.8 (2 C, C-6, C-6),
60.7, 60.5 (2 C, C-6, C-6), 52.7, 52.4 (2 C, C-2,
C-2), 23.2, 22.9 (2 C, CH3CONH), 20.9–20.5 (12 C,
CH3CO). Anal. Calcd for C56H80N2O35: C, 50.15; H,
6.01; N, 2.09. Found: C, 50.08; H, 5.80; N, 1.92.
1-[2,3,4,6-Tetra-O-acetyl--D-galactopyranosyl-
(14)-3,6-di-O-acetyl-2-acetamido-2-deoxy--D-
glucopyranosyloxy-8-[2,3,4,6-tetra-O-acetyl--D-
galactopyranosyl-(14)-3,6-di-O-acetamido-2-deoxy--
D-glucopyranosyloxy-3-dioxaoctane (20)
Compound 20 was prepared as described for the prepa-
ration of 19. The crude product was purified by chro-
matography with 35:1 CHCl3–MeOH to afford a
colorless syrup in 56% yield; [ ]D25 +13.5° (c 0.89,
CHCl3); 1H NMR (CDCl3):  6.60, 6.51 (d, 2 H, NH,
NH), 5.36 (dd, 2 H, H-4, H-4), 5.23 (dd, 1 H, H-3),
5.13–5.11 (m, 2 H, H-2, H-2), 5.05 (1 H, H-3),
4.97–4.95 (m, 2 H, H-3, H-3), 4.80 (d, 1 H, J1, 2 3.50
Hz, H-1), 4.66 (d, 1 H, J1, 2 8.00 Hz, H-1), 4.51 (d,
2H, J1, 2 8.00 Hz, H-1, H-1), 4.45, 4.12–4.10 (m, 8
H, H-6a, 6b, H-6a, 6b, H-6a, 6b, H-6a, 6b), 4.27
(dd, 1 H, H-2), 4.07 (dd, 1 H, H-2), 3.93–3.78 (m, 6
H, H-4, 5, H-5, H-4, 5, H-5), 3.77–3.62 (m, 12 H,
CH2O), 2.16–1.96 (14s, 42 H, CH3CONH,
CH3CONH, 12×CH3CO); 13C NMR (CDCl3): 
170.9–169.2 (14 C, CH3CONH, CH3CONH, 12×
CH3CO), 101.5 (C-1), 101.2 (C-1), 101.1 (C-1), 97.5
(C-1), 76.3 (C-4), 76.2 (C-4), 73.1 (CH2O), 72.6
(C-3), 72.5 (CH2O), 71.5 (C-3), 71.1, 71.0 (2 C, C-3,
C-3), 70.9, 70.6 (2 C, C-5, C-5), 70.9 (CH2O), 70.5
(CH2O), 69.9 (CH2O), 69.2, 69.0 (2 C, C-2, C-2),
68.5 (2 C, C-5, C-5), 67.2 (CH2O), 66.5, 66.4 (2 C,
C-4, C-4), 62.2, 61.9 (2 C, C-6, C-6), 60.7, 60.5 (2
C, C-6, C-6), 53.3, 51.7 (2 C, C-2, C-2), 23.1, 23.0
(2 C, CH3CONH, CH3CONH), 20.9–20.5 (12 C,
CH3CO). Anal. Calcd for C58H84N2O36: C, 50.29; H,
6.11; N, 2.02. Found: C, 50.46; H, 6.39; N, 1.85.
3-Oxapent-1,5-diyl bis[2,3,4,6-tetra-O-acetyl--D-
galactopyranosyl-(14)-3,6-di-O-acetyl-2-acetamido-2-
deoxy--D-glucopyranoside] (21)
Compound 21 was prepared as described for the prepa-
ration of 19. The crude product was purified by chro-
matography with 35:1 CHCl3–MeOH to afford a
colorless syrup in 50% yield; [ ]D25 +5.3° (c 2.28,
CHCl3); 1H NMR (CDCl3):  6.81 (d, 1 H, NH), 5.36
(d, 1 H, H-4), 5.15 (dd, 1 H, H-2), 5.07 (dd, 1 H, H-3),
4.98 (dd, 1 H, H-3), 4.77 (d, 1 H, J1, 2 8.00 Hz, H-1),
4.54 (d, 1 H, J1, 2 7.25 Hz, H-1), 4.45, 4.16–4.07 (m, 4
H, H-6a, 6b, H-6a, 6b), 4.06 (dd, 1 H, H-2), 3.91 (m,
1 H, H-5), 3.86 (m, 1 H, H-5), 3.82 (m, 1 H, H-4),
3.78–3.60 (m, 4 H, CH2O), 2.19–1.95 (7s, 21 H, 6×
CH3CO, NHCOCH3); 13C NMR (CDCl3):  171.0–
169.2 (7 C, 6×COCH3, NHCOCH3), 101.5 (C-1),
101.1 (C-1), 75.9 (C-4), 72.9 (CH2O), 72.7 (C-3), 70.8
(C-3), 70.6 (C-5), 69.2 (C-2), 68.4 (C-5), 67.5 (CH2O),
66.5 (C-4), 62.1 (C-6), 60.7 (C-6), 52.7 (C-2), 22.9
(CH3CONH), 20.9–20.5 (6 C, CH3CO). Anal. Calcd
for C56H80N2O35: C, 50.15; H, 6.01; N, 2.09. Found: C,
49.89; H, 6.26; N, 1.85.
3,6-Dioxaoct-1,8-diyl bis[2,3,4,6-tetra-O-acetyl--
D-galactopyranosyl-(14)-3,6-di-O-acetyl-2-acetamido-
2-deoxy--D-glucopyranoside] (22)
Compound 22 was prepared as described for the prepa-
ration of 19. The crude product was purified by chro-
matography with 35:1 CHCl3–MeOH to afford a
colorless syrup in 52% yield; [ ]D25 +8.2° (c 0.98,
CHCl3); 1H NMR (CDCl3):  6.55 (d, 1 H, NH), 5.35
(d, 1 H, H-4), 5.11 (dd, 1 H, H-2), 5.04 (dd, 1 H, H-3),
4.96 (dd, 1 H, H-3), 4.66 (d, 1 H, J1, 2 8.00 Hz, H-1),
4.50 (d, 1 H, J1, 2 8.00 Hz, H-1), 4.48, 4.13–4.07 (m, 4
H, H-6a, 6b, H-6a, 6b), 4.04 (m, 1 H, H-2), 3.91 (m, 1
H, H-5), 3.86 (m, 1 H, H-5), 3.83 (m, 1 H, H-4),
3.78–3.62 (m, 6 H, CH2O), 2.17–1.97 (7s, 21 H, 6×
CH3CO, CH3CONH); 13C NMR (CDCl3):  171.1
(NHCOCH3), 170.4–169.2 (6 C, COCH3), 101.5 (C-1),
101.2 (C-1), 76.2 (C-4), 73.1 (CH2O), 72.8 (C-3), 71.0
(C-3), 70.6 (C-5), 70.5 (CH2O), 69.4 (CH2O), 69.3
(C-2), 68.5 (C-5), 66.7 (C-4), 62.4 (C-6), 60.8 (C-6),
53.3 (C-2), 23.0 (CH3CONH), 20.8–20.4 (6 C,
CH3CO). Anal. Calcd for C58H84N2O36: C, 50.29; H,
6.11; N, 2.02. Found: C, 50.54; H, 6.16; N, 1.71.
3-Oxapent-1,5-diyl bis[2,3,4,6-tetra-O-acetyl--D-
galactopyranosyl-(14)-3,6-di-O-acetyl-2-acetamido-2-
deoxy--D-glucopyranoside] (23)
Compound 23 was prepared as described for the prepa-
ration of 19. The crude product was purified by chro-
matography with 35:1 CHCl3–MeOH to afford a
colorless syrup in 48% yield; [ ]D25 +50.5° (c 1.03,
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CHCl3); 1H NMR (CDCl3):  6.40 (d, 1 H, NH), 5.35
(d, 1 H, H-4), 5.24 (dd, 1 H, H-3), 5.12 (dd, 1 H, H-2),
4.96 (dd, 1 H, H-3), 4.84 (d, 1 H, J1, 2 3.25 Hz, H-1),
4.52 (d, 1 H, J1, 2 7.50 Hz, H-1), 4.46, 4.13–4.07 (m, 4
H, H-6a, 6b, H-6a, 6b), 4.26 (dd, 1 H, H-2), 3.90 (m,
1 H, H-5), 3.87 (m, 1 H, H-5), 3.80 (m, 1 H, H-4),
3.77–3.64 (m, 4 H, CH2O), 2.15–1.97 (7s, 21 H, 6×
CH3CO, NHCOCH3); 13C NMR (CDCl3):  170.9–
169.1 (7 C, 6×COCH3, NHCOCH3), 101.3 (C-1), 97.3
(C-1), 76.4 (C-4), 71.4 (C-3), 71.0 (C-3), 70.7 (C-5),
70.0 (CH2O), 69.3 (C-2), 68.7 (C-5), 67.1 (CH2O), 66.7
(C-4), 61.9 (C-6), 60.8 (C-6), 52.0 (C-2), 23.0
(CH3CONH), 20.9–20.4 (6 C, CH3CO). Anal. Calcd
for C56H80N2O35: C, 50.15; H, 6.01; N, 2.09. Found: C,
50.08; H, 5.80; N, 1.83.
3,6-Dioxaoct-1,8-diyl bis[2,3,4,6-tetra-O-acetyl--
D-galactopyranosyl-(14)-3,6-di-O-acetyl-2-acetamido-
2-deoxy--D-glucopyranoside] (24)
Compound 24 was prepared as described for the prepa-
ration of 19. The crude product was purified by chro-
matography with 35:1 CHCl3–MeOH to afford a
colorless syrup in 50% yield; [ ]D25 +34.3° (c 1.75,
CHCl3); 1H NMR (CDCl3):  6.30 (d, 1 H, NH), 5.35
(d, 1 H, H-4), 5.25 (dd, 1 H, H-3), 5.11 (dd, 1 H, H-2),
4.98 (dd, 1 H, H-3), 4.80 (d, 1 H, J1, 2 3.50 Hz, H-1),
4.52 (d, 1 H, J1, 2 8.00 Hz, H-1), 4.46, 4.13–4.09 (m, 4
H, H-6a, 6b, H-6a, 6b), 4.26 (m, 1 H, H-2), 3.95 (m, 1
H, H-5), 3.88 (m, 1 H, H-5), 3.82 (m, 1 H, H-4),
3.77–3.62 (m, 6 H, CH2O), 2.15–1.96 (7s, 21 H, 6×
CH3CO, CH3CONH); 13C NMR (CDCl3):  170.9–
169.2 (7 C, 6×COCH3, NHCOCH3), 101.3 (C-1), 97.4
(C-1), 76.4 (C-4), 71.5 (C-3), 71.0 (C-3), 70.5 (C-5),
70.4 (CH2O), 69.9 (CH2O), 69.1 (C-2), 68.4 (C-5), 67.4
(CH2O), 66.5 (C-4), 61.9 (C-6), 60.6 (C-6), 51.8 (C-2),
23.0 (CH3CONH), 20.9–20.5 (6 C, CH3CO). Anal.
Calcd for C58H84N2O36: C, 50.29; H, 6.11; N, 2.02.
Found: C, 50.44; H, 6.35; N, 1.76.
5-Hydroxy-3-oxapentyl -D-galactopyranosyl-(1
4)-2-acetamido-2-deoxy--D-glucopyranoside (25)
A catalytic amount of sodium was added to a solution
of compound 15 (0.1 g) in methanol (5 mL). The
mixture was stirred at room temperature for 12 h, then
neutralized with H+ cation exchange resin. The solu-
tion was filtered and concentrated and the residue was
dissolved in 10 mL water and freeze-dried to give 25 as
a white solid (0.062 g, 95%); [ ]D25 −83.9° (c 0.62,
H2O); 1H NMR (D2O):  4.64 (d, 1 H, J1, 2 8.10 Hz,
H-1), 4.52 (d, 1 H, J1, 2 7.50 Hz, H-1), 4.06–3.69 (m,
20 H, H-2, 3, 4, 5, 6a, 6b, H-2, 3, 4, 5, 6a, 6b,
CH2O), 2.09 (s, 3 H, NHCOCH3); 13C NMR (D2O): 
171.5 (NHCO), 99.9 (C-1), 98.0 (C-1), 75.6 (C-4), 72.4,
71.8, 69.6, 69.5, 68.8, 68.0, 66.6, 66.0, 57.4 (9 C, C-3,
C-5, C-2, C-3, C-5, CH2O), 65.6 (C-4), 58.0 (C-6),
57.2 (C-6), 52.1 (C-2), 19.2 (CH3CONH). ESI-TOFF-
MS: m/z 472.2 [M+1]+.
8-Hydroxy-3,6-dioxaoctyl -D-galactopyranosyl-
(14)-2-acetamido-2-deoxy--D-glucopyranoside (26)
Compound 26 was prepared as described for the prepa-
ration of 25. The yield was 97%; [ ]D25 −105.3° (c 0.76,
H2O); 1H NMR (D2O):  4.58 (d, 1 H, J1, 2 7.80 Hz,
H-1), 4.46 (d, 1 H, J1, 2 7.50 Hz, H-1), 3.96–3.64 (m,
24 H, H-2, 3, 4, 5, 6a, 6b, H-2, 3, 4, 5, 6a, 6b,
CH2O), 2.03 (s, 3 H, NHCOCH3); 13C NMR (D2O): 
171.2 (NHCO), 99.3 (C-1), 97.5 (C-1), 75.7 (C-4), 72.7,
72.0, 70.7, 69.8, 68.5, 68.0, 66.6, 66.3, 64.9, 57.8, 57.3
(11 C, C-3, C-5, C-2, C-3, C-5, CH2O), 64.9 (C-4),
57.8 (C-6), 57.1 (C-6), 52.3 (C-2), 19.7 (CH3CONH).
ESI-TOFF-MS: m/z 516.2 [M+1]+.
5-Hydroxy-3-oxapentyl -D-galactopyranosyl-(1
4)-2-acetamido-2-deoxy--D-glucopyranoside (27)
Compound 27 was prepared as described for the prepa-
ration of 25. The yield was 96%; [ ]D25 +70.6° (c 0.68,
H2O); 1H NMR (CD3OD):  4.82 (d, 1 H, J1, 2 3.60 Hz,
H-1), 4.36 (d, 1 H, J1, 27.50 Hz, H-1), 3.93–3.60 (m, 18
H, H-2, 3, 4, 5, 6a, 6b, H-4, 5, 6a, 6b, CH2O), 3.57
(dd, 1 H, H-2), 3.50 (dd, 1 H, H-3), 1.98 (s, 3 H,
NHCOCH3); 13C NMR (CD3OD):  173.6 (NHCO),
105.2 (C-1), 98.6 (C-1), 81.5 (C-4), 77.1 (C-5), 74.9
(C-3), 73.6, 72.3, 71.2, 71.1, 70.3, 62.2 (6 C, C-3, C-5,
CH2O), 72.6 (C-2), 68.2 (C-4), 62.5 (C-6), 62.0 (C-6),
54.9 (C-2), 22.6 (CH3CONH). ESI-TOFF-MS: m/z
472.2 [M+1]+.
8-Hydroxy-3,6-dioxaoctyl -D-galactopyranosyl-
(14)-2-acetamido-2-deoxy--D-glucopyranoside (28)
Compound 28 was prepared as described for the prepa-
ration of 25. The yield was 98%; [ ]D25 +64.9° (c 0.37,
H2O); 1H NMR (CD3OD):  4.81 (d, 1 H, J1, 2 3.30 Hz,
H-1), 4.37 (d, 1 H, J1, 2 7.80 Hz, H-1), 3.98–3.62 (m,
22 H, H-2, 3, 4, 5, 6a, 6b, H-4, 5, 6a, 6b, CH2O), 3.56
(dd, 1 H, H-2), 3.50 (dd, 1 H, H-3), 1.98 (s, 3 H,
NHCOCH3); 13C NMR (CD3OD):  173.6 (NHCO),
105.1 (C-1), 98.6 (C-1), 81.4 (C-4), 77.1 (C-5), 74.9
(C-3), 73.7, 72.3, 71.6, 71.4, 71.2, 71.1, 70.3, 62.2 (8 C,
C-3, C-5, CH2O), 72.6 (C-2), 68.1 (C-4), 62.5 (C-6),
62.0 (C-6), 54.9 (C-2), 22.6 (CH3CONH). ESI-TOFF-
MS: m/z 516.2 [M+1]+.
1-[-D-Galactopyranosyl-(14)-2-acetamido-2-
deoxy--D-glucopyranosyloxy-5-[-D-galactopyranosyl-
(14)-2-acetamido-2-deoxy--D-glucopyranosyloxy]-3-
oxapentane (29)
Compound 29 was prepared as described for the prepa-
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ration of 25. The yield was 97%; [ ]D25 +31.8° (c 0.63,
H2O); 1H NMR (D2O):  4.82 (d, 1 H, J1, 2 3.50 Hz,
H-1), 4.52 (d, 1 H, J1, 2 8.00 Hz, H-1), 4.41 (d, 2 H,
J1, 2 7.50 Hz, H-1, H-1), 3.94–3.65 (m, 28 H, H-2,
3, 4, 5, 6a, 6b, H-4, 5, 6a, 6b, H-2, 3, 4, 5, 6a, 6b,
H-4, 5, 6a, 6b, CH2O), 3.61 (dd, 2 H, H-2, H-2),
3.48 (dd, 2 H, H-3, H-3), 1.98 (s, 6 H, 2×
NHCOCH3); 13C NMR (D2O):  175.0, 174.9 (2 C,
NHCO), 103.4 (C-1), 103.2 (C-1), 101.6 (C-1), 97.4
(C-1), 79.2, 78.9 (2 C, C-4, C-4), 75.9, 75.3 (2 C,
C-5, C-5), 73.3, 73.0 (2 C, C-3, C-3), 71.5, 71.2 (2
C, C-2, C-2), 70.4, 70.3, 70.2, 69.6, 69.5, 67.4 (6 C,
C-3, C-3, C-5, C-5, CH2O), 69.1, 68.9 (2 C, C-4,
C-4), 61.6, 60.6 (2 C, C-6, C-6), 60.4, 60.3 (2 C,
C-6, C-6), 55.6, 53.7 (2 C, C-2, C-2), 22.7, 22.4 (2
C, CH3CONH). ESI-TOFF-MS: m/z 837.3 [M+1]+.
1-[-D-Galactopyranosyl-(14)-2-acetamido-2-
deoxy--D-glucopyranosyloxy-8-[-D-galactopyranosyl-
(14)-2-acetamido-2-deoxy--D-glucopyranosyloxy]-
3,6-dioxaoctane (30)
Compound 30 was prepared as described for the prepa-
ration of 25. The yield was 98%; [ ]D25 +30.3° (c 0.66,
H2O); 1H NMR (D2O):  4.83 (d, 1 H, J1, 2 3.30 Hz,
H-1), 4.53 (d, 1 H, J1, 2 8.00 Hz, H-1), 4.41 (d, 2 H,
J1, 2 7.50 Hz, H-1, H-1), 3.94–3.65 (m, 28 H, H-2,
3, 4, 5, 6a, 6b, H-4, 5, 6a, 6b, H-2, 3, 4, 5, 6a, 6b,
H-4, 5, 6a, 6b, CH2O), 3.62 (dd, 2 H, H-2, H-2),
3.49 (dd, 2 H, H-3, H-3), 1.98 (s, 6 H, 2×
NHCOCH3); 13C NMR (D2O):  175.1, 174.9 (2 C,
NHCO), 103.4 (C-1), 103.2 (C-1), 101.6 (C-1), 97.4
(C-1), 79.2, 78.9 (2 C, C-4, C-4), 75.9, 75.3 (2 C,
C-5, C-5), 73.3, 73.0 (2 C, C-3, C-3), 71.5, 71.2 (2
C, C-2, C-2), 70.4, 70.2, 70.1, 69.6, 69.5, 67.3, 67.1 (7
C, C-3, C-3, C-5, C-5, CH2O), 69.1, 68.9 (2 C, C-4,
C-4), 61.6, 60.6 (2 C, C-6, C-6), 60.4, 60.2 (2 C,
C-6, C-6), 55.6, 53.7 (2 C, C-2, C-2), 22.7, 22.5 (2
C, CH3CONH). ESI-TOFF-MS: m/z 881.4 [M+1]+.
3-Oxapent-1,5-diyl bis(-D-galactopyranosyl-(1
4)-2-acetamido-2-deoxy--D-glucopyranoside) (31)
Compound 31 was prepared as described for the prepa-
ration of 25. The yield was 94%; [ ]D25 +26.7° (c 1.20,
H2O); 1H NMR (CD3OD):  4.51 (d, 1 H, J1, 2 8.00 Hz,
H-1), 4.38 (d, 1 H, J1, 2 7.50 Hz, H-1), 3.97–3.48 (m,
16 H, H-2, 3, 4, 5, 6a, 6b, H-2, 3, 4, 5, 6a, 6b,
CH2O), 2.02 (s, 3 H, NHCOCH3); 13C NMR (CD3OD):
 174.0 (NHCO), 105.1 (C-1), 102.6 (C-1), 81.6 (C-4),
77.2 (C-5), 74.9 (C-3), 72.6 (C-2), 72.3, 71.5, 71.2, 70.4
(4 C, C-3, C-5, CH2O), 68.2 (C-4), 62.5 (C-6), 62.0
(C-6), 55.1 (C-2), 22.5 (CH3CONH). ESI-TOFF-MS:
m/z 837.3 [M+1]+.
3,6-Dioxaoct-1,8-diyl bis[-D-galactopyranosyl-
(14)-2-acetamido-2-deoxy--D-glucopyranoside] (32)
Compound 32 was prepared as described for the prepa-
ration of 25. The yield was 98%; [ ]D25 +21.7° (c 0.92,
H2O); 1H NMR (CD3OD):  4.53 (d, 1 H, J1, 2 8.00 Hz,
H-1), 4.39 (d, 1 H, J1, 2 7.50 Hz, H-1), 3.96–3.54 (m,
18 H, H-2, 3, 4, 5, 6a, 6b, H-2, 3, 4, 5, 6a, 6b,
CH2O), 1.99 (s, 3 H, NHCOCH3); 13C NMR (CD3OD):
 174.2 (NHCO), 104.8 (C-1), 102.6 (C-1), 81.0 (C-4),
76.9 (C-5), 74.5 (C-3), 72.5 (C-2), 72.2, 71.4, 71.1,
70.1, 69.9 (5 C, C-3, C-5, CH2O), 68.1 (C-4), 62.4
(C-6), 61.8 (C-6), 56.6 (C-2), 23.2 (CH3CONH). ESI-
TOFF-MS: m/z 903.3 [M+Na]+.
3-Oxapent-1,5-diyl bis[-D-galactopyranosyl-(1
4)-2-acetamido-2-deoxy--D-glucopyranoside] (33)
Compound 33 was prepared as described for the prepa-
ration of 25. The yield was 95%; [ ]D25 +38.7° (c 1.24,
H2O); 1H NMR (CD3OD):  4.85 (d, 1 H, J1, 2 3.50 Hz,
H-1), 4.39 (d, 1 H, J1, 2 7.50 Hz, H-1), 3.97–3.68 (m,
14 H, H-2, 3, 4, 5, 6a, 6b, H-4, 5, 6a, 6b, CH2O), 3.62
(dd, 1 H, H-2), 3.54 (dd, 1 H, H-3), 2.01 (s, 3 H,
NHCOCH3); 13C NMR (CD3OD):  174.0 (NHCO),
104.9 (C-1), 98.5 (C-1), 81.2 (C-4), 77.0 (C-5), 74.7
(C-3), 72.6 (C-2), 72.2, 71.3, 71.0, 70.2 (4 C, C-3, C-5,
CH2O), 68.1 (C-4), 62.4 (C-6), 61.8 (C-6), 54.8 (C-2),
22.8 (CH3CONH). ESI-TOFF-MS: m/z 859.3 [M+
Na]+.
3,6-Dioxaoct-1,8-diyl bis[-D-galactopyranosyl-
(14)-2-acetamido-2-deoxy--D-glucopyranoside] (34)
Compound 34 was prepared as described for the prepa-
ration of 25. The yield was 93%; [ ]D25 +55.8° (c 0.86,
H2O); 1H NMR (CD3OD):  4.84 (d, 1 H, J1, 2 3.50 Hz,
H-1), 4.37 (d, 1 H, J1, 2 7.50 Hz, H-1), 3.97–3.63 (m,
16 H, H-2, 3, 4, 5, 6a, 6b, H-4, 5, 6a, 6b, CH2O), 3.55
(dd, 1 H, H-2), 3.49 (dd, 1 H, H-3), 1.99 (s, 3 H,
NHCOCH3); 13C NMR (CD3OD):  173.5 (NHCO),
105.2 (C-1), 98.7 (C-1), 81.5 (C-4), 77.2 (C-5), 75.0
(C-3), 72.7 (C-2), 72.3, 71.6, 71.4, 71.2, 70.4 (5 C, C-3,
C-5, CH2O), 68.2 (C-4), 62.5 (C-6), 62.0 (C-6), 55.0
(C-2), 22.7 (CH3CONH). ESI-TOFF-MS: m/z 881.4
[M+1]+.
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